Allara Health Secures $26M in Series B Funding for Cross-Country Expansion
TL/DR –
Allara Health, a virtual healthcare platform for women with chronic hormonal conditions, has raised $26 million in a Series B funding round led by Index Ventures, with participation from Google Ventures (GV). The investment will facilitate nationwide specialized care for women and has increased Allara’s total funding to $38.5 million. In 2024, Allara grew fourfold, launched its care model across the US, formed new insurance alliances, and appointed a new Chief Medical Officer, Dr. Heather Huddleston.
Allara Health Secures $26 Million in Series B Funding for Women’s Hormonal Health
Allara Health, a pioneering virtual care platform for women dealing with chronic hormonal issues, recently announced the completion of its $26 million Series B funding round. This injection of capital, led by Index Ventures and supported by existing investor GV (Google Ventures), takes Allara Health’s total funding to $38.5 million and will support its nationwide expansion.
Chronic hormonal conditions like Polycystic Ovarian Syndrome (PCOS), endometriosis, and hypothyroidism affect 1 in 3 women, often leading to health complications such as high-risk pregnancies, obesity, and diabetes. However, getting a diagnosis and finding quality care remains a struggle for many – nearly 70% of PCOS cases are undiagnosed, and it can take up to 10 years to receive a diagnosis of endometriosis.
“Allara was founded to tackle the pervasive inequality in healthcare for women suffering from complex hormonal conditions,” said founder and CEO Rachel Blank. “We are committed to providing affordable, accessible care that addresses their health concerns, alleviates symptoms, and allows them to lead fulfilling lives. This funding will enhance our ability to deliver on this mission.”
Allara’s team of endocrinologists, OB-GYNs, nurse practitioners, and Registered Dietitians take a comprehensive approach to patient care, offering personalized, evidence-based solutions that empower patients in managing their health. After a few weeks of treatment with Allara, over 75% of patients reported increased control over their health and improved outlook on their health outcomes.
2024 marked a significant year for Allara, with the company seeing a 4x growth, expansion across all 50 U.S. states, and securing new insurance partnerships with leading health plans such as Aetna, Blue Cross Blue Shield, Cigna, Humana, and United Healthcare. The company also bolstered its clinical team, appointing Dr. Heather Huddleston, a reproductive endocrinology and infertility specialist, as the new Chief Medical Officer.
“Allara is revolutionizing women’s healthcare by providing personalized, expert care at scale,” said Martin Mingot of Index Ventures. “This investment will help Allara continue to bridge the care divide for women battling hormonal conditions.”
More about Allara’s mission and services can be found at allarahealth.com.
About Allara Health
Allara Health is a specialist care platform designed to support millions of women living with complex hormonal and gynecologic conditions, such as PCOS and endometriosis. By connecting patients with expert practitioners and Registered Dietitians, Allara provides comprehensive, personalized healthcare online, fostering improved health outcomes and enabling patients to achieve their individual goals. Visit www.allarahealth.com for more information.
View original content and download multimedia: here.
SOURCE: Allara Health
—
Read More Health & Wellness News ; US News